Aphakia Clinical Trial
Official title:
Clinical Evaluation of the Lenstec Softec HP1 Intraocular Lens
The study is designed as a post market evaluation of the Softec HP1 IOL for continuance of the CE certificate. The primary effectiveness endpoint is to evaluate the safety and performance levels produced by this IOL in patients requiring standard cataract surgery. There will be no change from standard procedure, other than 1 extra post op evaluation.
Recruitment will be performed by the 3 Clinical Investigators (Jean-Pierre Danjoux - Sunderland Eye Infirmary, Karen Goodall - Croft Shifa Health Center, Mark Benson - Midland Eye Institute) and any appropriate, pre-trained staff within the hospital using the inclusion and exclusion criteria set out in the protocol. Patient selection will involve anyone over the age of 21 with an age-related cataract regardless of ethnicity, religion or gender. An Informed Consent Form (ICF) will be explained with patients in full which will be signed by both the Principal Investigator (PI) and the patient with full understanding. Understanding fully means that the patient understands the nature of the operation, the benefits to the operation and also any risks or burdens. The consent form also states alternatives to participation in the trial other than the option being put forward. The patients will be of sound enough mind to retain the information from the ICF and will be given time to digest this in order to make a free and effective decision to join the study. All risks and benefits are explained in the ICF and are no more or less than that of a standard cataract surgery provided on a daily basis by NHS consultants. All surgeries will be performed by the PI. Confidentiality shall be kept at all times with the PI and clinical staff using a unique patient reference number that in no instance indicates the identity of the patient to the study sponsor (Lenstec Inc.) or anyone else outside of the hospital. Any other confidentiality issues will run in conjunction with the hospital policy of which the staff involved in the study are aware. There are no tissue samples to be used in this study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A | |
| Terminated |
NCT00960700 -
A Multi Focal Visual Outcome Study Using Different Near Additions
|
N/A | |
| Completed |
NCT00773266 -
Intraocular Position of Secondary Iris-Fixated IOLs in Aphakic Eyes
|
N/A | |
| Completed |
NCT00838045 -
Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular Lens
|
Phase 4 | |
| Recruiting |
NCT05796453 -
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
|
N/A | |
| Completed |
NCT01230060 -
One-Piece Hydrophobic Acrylic Intraocular Lens in Subjects Undergoing Cataract Extraction
|
Phase 3 | |
| Completed |
NCT05481125 -
Clareon Toric vs Eyhance Toric
|
N/A | |
| Not yet recruiting |
NCT04516889 -
Evaluating Safety and Efficacy of a Modified Technique of Scleral Fixation Intraocular Lens Implantation
|
N/A | |
| Completed |
NCT03733730 -
Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs
|
N/A | |
| Completed |
NCT04098367 -
Clinical Investigation of the AcrySof IQ Vivity Extended Vision Intraocular Lens (IOL)
|
N/A | |
| Completed |
NCT04528069 -
Clinical Investigation of the Visual Outcomes and Safety of a Trifocal Toric IOL in an Asian Population
|
N/A | |
| Completed |
NCT05852470 -
Evaluation of Clareon Vivity/Vivity Toric
|
N/A | |
| Completed |
NCT01061281 -
Evaluation of the Tecnis™ Multifocal and Crystalens™ Accommodating Intraocular Lenses
|
Phase 4 | |
| Completed |
NCT00625313 -
Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens
|
N/A | |
| Completed |
NCT06389643 -
Comparison of Safety and Efficacy of Four-Point Scleral Intraocular Lens Fixation and Yamane Techniques
|
N/A | |
| Completed |
NCT03316885 -
Post-Market Clinical Investigation of the Clareon® IOL
|
N/A | |
| Completed |
NCT02418871 -
Evaluation of the FluidVision Accommodating Intraocular Lens (AIOL) With an Improved Injector System
|
N/A | |
| Completed |
NCT03054649 -
ClarVista HARMONI Toric Trial With Intraoperative Exchange
|
N/A | |
| Withdrawn |
NCT04800016 -
Real-World Study of Vivity Intraocular Lenses (IOLs)
|
N/A | |
| Recruiting |
NCT06401551 -
Clareon PanOptix Pro vs. Clareon PanOptix - Study B
|
N/A |